OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up
Angioletta Lasagna, Irene Cassaniti, Francesca Arena, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6731-6731
Open Access | Times Cited: 7
Angioletta Lasagna, Irene Cassaniti, Francesca Arena, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6731-6731
Open Access | Times Cited: 7
Showing 7 citing articles:
Longitudinal analysis of antibody titers after primary and booster mRNA COVID-19 vaccination can identify individuals at risk for breakthrough infection
Hyeongki Park, Naotoshi Nakamura, Shô Miyamoto, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Hyeongki Park, Naotoshi Nakamura, Shô Miyamoto, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Anti-SARS-CoV-2 B and T-Cell Immune Responses Persist 12 Months After mRNA Vaccination with BNT162b2 in Systemic Lupus Erythematosus Patients Independently of Immunosuppressive Therapies
Mario Ferraioli, Alessandra Aiello, I. Prevete, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 396-396
Open Access
Mario Ferraioli, Alessandra Aiello, I. Prevete, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 396-396
Open Access
In silico clinical studies for optimal COVID-19 vaccination schedules in patients with cancer
Chrysovalantis Voutouri, Corey Hardin, Vivek Naranbhai, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 3, pp. 101436-101436
Open Access | Times Cited: 2
Chrysovalantis Voutouri, Corey Hardin, Vivek Naranbhai, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 3, pp. 101436-101436
Open Access | Times Cited: 2
Pediatric cancer patients vaccinated against SARS-CoV-2—a clinical and laboratory follow-up
Benjamin Siebald, Andreas H. Groll, Sarah Salou, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 4
Open Access | Times Cited: 1
Benjamin Siebald, Andreas H. Groll, Sarah Salou, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 4
Open Access | Times Cited: 1
In silico clinical studies for the design of optimal COVID-19 vaccination schedules in patients with cancer
Rakesh K. Jain, Chrysovalantis Voutouri, C. Corey Hardin, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Rakesh K. Jain, Chrysovalantis Voutouri, C. Corey Hardin, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
COVID-19 Pandemic: Therapeutic Strategies and Vaccines
Mariarosaria Boccellino
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 556-556
Open Access | Times Cited: 1
Mariarosaria Boccellino
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 556-556
Open Access | Times Cited: 1
Pediatric Cancer Patients Vaccinated Against SARS-CoV-2 – A Clinical and Laboratory Follow-Up
Benjamin Siebald, Andreas H. Groll, Sarah Salou, et al.
Research Square (Research Square) (2023)
Open Access
Benjamin Siebald, Andreas H. Groll, Sarah Salou, et al.
Research Square (Research Square) (2023)
Open Access
